ENTITY
D.Western Therapeutics Institute Inc.

D.Western Therapeutics Institute Inc. (4576 JP)

13
Analysis
Health CareJapan
D.Western Therapeutics Institute Inc.(DWTI) is a biotechnology (bio-venture) company that focuses on development of new drugs. The Company's focus is on protein kinase inhibitors. DWTI discovers and develops several drugs, such as antiglaucoma, antihypertensive, neuroprotective, antithrombogenic, antiatherosclerosis and anticancer.
more
02 Jun 2023 06:21Issuer-paid

D. Western Therapeutics Institute (4576 JP) - News Flash

DWTI announced that out-license partner Dutch Ophthalmic Research Center (International) B.V. (DORC) has submitted a new drug application for...

Share
01 Jun 2023 09:20Issuer-paid

D. Western Therapeutics Institute (DWTI) (4576 JP) - 1Q Follow-Up

Development pipeline is steadily expanding FY23/12 initiatives: conducting H-1337 phase IIb trials in the US, DW-1002 approval/launch in China and...

Share
25 Jul 2018 18:44

Japan: Relative Price Score Short Portfolios

RELATIVE PRICE SCORE SHORT PORTFOLIOS - Our recent insight Japan: Most Overbought & Most Oversold - The Relative Price Score introduced our...

Logo
502 Views
Share
x